Biogen Inc (NASDAQ:BIIB)

401.71
Delayed Data
As of Apr 24
 -28.57 / -6.64%
Today’s Change
275.39
Today|||52-Week Range
480.18
+18.34%
Year-to-Date

Today’s Trading

Previous close430.28
Today’s open410.00
Day’s range395.00 - 410.87
Volume6,084,406
Average volume (3 months)1,903,652
Market cap$94.2B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+22.92%
Earnings growth (next 5 years)+14.80%
Revenue growth (last year)+39.61%
P/E ratio32.5
Price/Sales8.27
Price/Book8.72

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.26-0.74%
BAXBaxter International...-0.37-0.52%
GILDGilead Sciences-1.51-1.44%
JUNOJuno Therapeutics In...-1.06-1.84%
Data as of 4:14pm ET, 04/24/2015

Financials

Last reporting dateApril 24, 2015
EPS forecast (this quarter)$3.92
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers